Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

被引:369
作者
Zheng, YH
Irwin, D
Kurosu, T
Tokunaga, K
Sata, T
Peterlin, BM
机构
[1] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Microbiol & Immunol, Rosalind Russell Med Res Ctr, San Francisco, CA 94143 USA
[3] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan
关键词
D O I
10.1128/JVI.78.11.6073-6076.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recently, APOBEC3G has been identified as a host factor that blocks retroviral replication. It introduces G to A hypermutations in newly synthesized minus strand viral cDNA at the step of reverse transcription in target cells. Here, we identified the human APOBEC3F protein as another host factor that blocks human immunodeficiency virus type 1 (HIV-1) replication. Similar to APOBEC3G, APOBEC3F also induced G to A hypermutations in HIV genomic DNA, and the viral Vif protein counteracted its activity. Thus, APOBEC family members might have evolved as a general defense mechanism of the body against retroviruses, retrotransposons, and other mobile genetic elements.
引用
收藏
页码:6073 / 6076
页数:4
相关论文
共 50 条
  • [41] Pertussis toxin enhances human immunodeficiency virus type 1 replication
    Momoi, Y
    Ichiyama, K
    Chowdhury, IH
    Koyanagi, Y
    Yamamoto, N
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (04) : 373 - 379
  • [42] HYDROXYUREA AS AN INHIBITOR OF HUMAN IMMUNODEFICIENCY VIRUS-TYPE-1 REPLICATION
    LORI, F
    MALYKH, A
    CARA, A
    SUN, D
    WEINSTEIN, JN
    LISZIEWICZ, J
    GALLO, RC
    SCIENCE, 1994, 266 (5186) : 801 - 805
  • [43] Replication of human immunodeficiency virus type 1 from entry to exit
    Lever, Andrew M. L.
    Jeang, Kuan-Teh
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 84 (01) : 23 - 30
  • [44] Replication of human immunodeficiency virus type 1 from entry to exit
    Andrew M. L. Lever
    Kuan-Teh Jeang
    International Journal of Hematology, 2006, 84 : 23 - 30
  • [45] Clinical significance of human immunodeficiency virus type 1 replication fitness
    Dykes, Carrie
    Demeter, Lisa M.
    CLINICAL MICROBIOLOGY REVIEWS, 2007, 20 (04) : 550 - +
  • [46] Role of the DIS hairpin in replication of human immunodeficiency virus type 1
    Berkhout, B
    vanWamel, JLB
    JOURNAL OF VIROLOGY, 1996, 70 (10) : 6723 - 6732
  • [47] The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication
    Roy, J
    Paquette, JS
    Fortin, JF
    Tremblay, MJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) : 3447 - 3455
  • [48] Various strategies for developing APOBEC3G protectors to circumvent human immunodeficiency virus type 1
    Bao, Qiqi
    Zhou, Jinming
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 250
  • [49] Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1
    Miyagij, Eri
    Opi, Sandrine
    Takeuchi, Hiroaki
    Khan, Mohammad
    Goila-Gaur, Ritu
    Kao, Sandra
    Strebel, Klaus
    JOURNAL OF VIROLOGY, 2007, 81 (24) : 13346 - 13353
  • [50] Human APOBEC3 Induced Mutation of Human Immunodeficiency Virus Type-1 Contributes to Adaptation and Evolution in Natural Infection
    Kim, Eun-Young
    Lorenzo-Redondo, Ramon
    Little, Susan J.
    Chung, Yoon-Seok
    Phalora, Prabhjeet K.
    Berry, Irina Maljkovic
    Archer, John
    Penugonda, Sudhir
    Fischer, Will
    Richman, Douglas D.
    Bhattacharya, Tanmoy
    Malim, Michael H.
    Wolinsky, Steven M.
    PLOS PATHOGENS, 2014, 10 (07)